Vancouver, B.C., tissue ‘bioprinting’ company inks $75M deal with Novo Nordisk for diabetes, obesity Vancouver, B.C.-based biotech company Aspect Biosystems inked a partnership worth potentially more than $2.6 billion with Danish biopharma giant Novo… Read More
